<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940617-1-00084</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4702 -->  <!-- PJG ITAG l=11 g=1 f=1 --> Fluorosalan was not classified as an OTC topical  <!-- PJG 0012 frnewline --> antimicrobial ingredient in the previous tentative final  <!-- PJG 0012 frnewline --> monograph because the agency stated that final regulatory action  <!-- PJG 0012 frnewline --> had been taken against ``*&blank;*&blank;* the halogenated salicylanilides,  <!-- PJG 0012 frnewline --> particularly *&blank;*&blank;* fluorosalan (21 CFR 310.508) *&blank;*&blank;*'' (43 FR  <!-- PJG 0012 frnewline --> 1210 at 1227). Although no comments were received, the agency  <!-- PJG 0012 frnewline --> notes that fluorosalan was not addressed in the final rule for  <!-- PJG 0012 frnewline --> halogenated salicylanilides (21 CFR 310.508), published in the  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  of October 30, 1975 (40 FR 5027). In reviewing  <!-- PJG 0012 frnewline --> the Antimicrobial I Panel's recommendations, the agency has  <!-- PJG 0012 frnewline --> determined that the Panel did not intend to include fluorosalan  <!-- PJG 0012 frnewline --> in the group of halogenated salicylanilides which it recommended  <!-- PJG 0012 frnewline --> be handled more expeditiously by the agency in a separate  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal  <!-- PJG 0012 frnewline --> Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  notice. (See the notice of proposed rulemaking for  <!-- PJG 0012 frnewline --> certain halogenated salicylanilides as active or inactive  <!-- PJG 0012 frnewline --> ingredients in drug and cosmetic products (September 13, 1974, 39  <!-- PJG 0012 frnewline --> FR 33102) and the advance notice of proposed rulemaking for OTC  <!-- PJG 0012 frnewline --> topical antimicrobial drug products (September 13, 1974, 39 FR  <!-- PJG 0012 frnewline --> 33103 at 33120).) The agency affirms the recommendation of the  <!-- PJG 0012 frnewline --> Antimicrobial I Panel (39 FR 33121) that fluorosalan be  <!-- PJG 0012 frnewline --> classified as Category II for use in antiseptic handwash,  <!-- PJG 0012 frnewline --> health-care personnel handwash, patient preoperative skin  <!-- PJG 0012 frnewline --> preparation, and surgical hand scrub drug products.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> The following charts are included as a summary of the  <!-- PJG 0012 frnewline --> categorization of health-care antiseptic active ingredients  <!-- PJG 0012 frnewline --> proposed by the agency. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 4,L2,i1,s100,xls75,xls75,xls75 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=95 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=4 --> Topical Antimicrobial Ingredients1 Summary of Health-Care Antiseptic Active Ingredients  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Active ingredient  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Patient preoperative skin preparation <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Antiseptic handwash or health-care personnel handwash  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Surgical hand scrub  <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=4 --> Alcohol 60 to 95 percent2  <!-- PJG 007 0104 intable --> I  <!-- PJG 007 0104 intable --> I  <!-- PJG 007 0104 intable --> I  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Benzalkonium chloride  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIISE4  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Benzethonium chloride  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Chlorhexidine gluconate2  <!-- PJG 007 0104 intable --> ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=5 f=1 --> 5 <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> )  <!-- PJG 007 0104 intable --> ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=5 f=1 --> 5 <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> )  <!-- PJG 007 0104 intable --> ( <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=5 f=1 --> 5 <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> )  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Chloroxylenol  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Cloflucarban  <!-- PJG 007 0104 intable --> II  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 007 0104 intable --> II  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Fluorosalan  <!-- PJG 007 0104 intable --> II  <!-- PJG 007 0104 intable --> II  <!-- PJG 007 0104 intable --> II  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Hexachlorophene  <!-- PJG 007 0104 intable --> II  <!-- PJG 007 0104 intable --> II  <!-- PJG 007 0104 intable --> II  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Hexylresorcinol  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Iodine Active Ingredients:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=3 --> Iodine complex (ammonium  <!-- PJG 0012 frnewline --> ether sulfate and  <!-- PJG 0012 frnewline --> polyoxyethylene  <!-- PJG 0012 frnewline --> sorbitan monolaurate)2  <!-- PJG 007 0104 intable --> NA  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Iodine complex  <!-- PJG 0012 frnewline --> (phosphate ester of  <!-- PJG 0012 frnewline --> alkylaryloxy  <!-- PJG 0012 frnewline --> polyethylene glycol)  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIIE <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Iodine tincture U.S.P  <!-- PJG 007 0104 intable --> I  <!-- PJG 007 0104 intable --> NA  <!-- PJG 007 0104 intable --> NA  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Iodine topical solution U.S.P  <!-- PJG 007 0104 intable --> I  <!-- PJG 007 0104 intable --> NA  <!-- PJG 007 0104 intable --> NA  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Nonylphenoxypoly  <!-- PJG 0012 frnewline --> (ethyleneoxy) ethanoliodine  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIIE <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Poloxamer-iodine complex  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Povidone-iodine  <!-- PJG 0012 frnewline --> 5 to 10 percent  <!-- PJG 007 0104 intable --> I  <!-- PJG 007 0104 intable --> I  <!-- PJG 007 0104 intable --> I  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Undecoylium chloride  <!-- PJG 0012 frnewline --> iodine complex  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIIE <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Isopropyl alcohol 70&hyph;91.3 percent2  <!-- PJG 007 0104 intable --> I  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Mercufenol chloride2  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> NA  <!-- PJG 007 0104 intable --> NA  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Methylbenzethonium chloride  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Phenol (less than 1.5 percent)  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Phenol (greater than  <!-- PJG 0012 frnewline --> 1.5 percent)  <!-- PJG 007 0104 intable --> II  <!-- PJG 007 0104 intable --> II  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Secondary amyltricresols2  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Sodium oxychlorosene2  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Tribromsalan3  <!-- PJG 007 0104 intable --> II  <!-- PJG 007 0104 intable --> II  <!-- PJG 007 0104 intable --> II  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Triclocarban  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Triclosan  <!-- PJG 007 0104 intable --> IIIE  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=3 --> Combinations  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=3 --> Calomel, oxyquinoline  <!-- PJG 0012 frnewline --> benzoate, triethanolamine,  <!-- PJG 0012 frnewline --> and phenol derivative2  <!-- PJG 007 0104 intable --> II  <!-- PJG 007 0104 intable --> NA  <!-- PJG 007 0104 intable --> NA  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Mercufenol chloride  <!-- PJG 0012 frnewline --> and secondary  <!-- PJG 0012 frnewline --> amyltricresols in  <!-- PJG 0012 frnewline --> 50 percent alcohol2  <!-- PJG 007 0104 intable --> IIISE  <!-- PJG 007 0104 intable --> NA  <!-- PJG 007 0104 intable --> NA <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Triple Dye  <!-- PJG 007 0104 intable --> II  <!-- PJG 007 0104 intable --> NA  <!-- PJG 007 0104 intable --> NA  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable --> 1_All ingredients (unless otherwise noted) in Antimicrobial I Drug  <!-- PJG 0012 frnewline --> Products Advance Notice of Proposed Rulemaking (39 FR 33103) and Tentative  <!-- PJG 0012 frnewline --> Final Monograph (47 FR 1210).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable --> 2_Not categorized in previous tentative final monograph, but  <!-- PJG 0012 frnewline --> categorized in this amended tentative final monograph.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable --> NA=Not Applicable because not evaluated for this use.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable --> 3_Categorized in Antimicrobial I Drug Products Advance Notice of  <!-- PJG 0012 frnewline --> Proposed Rulemaking (39 FR 33103) and in Certain Halogenated Salicylanilides  <!-- PJG 0012 frnewline --> as Active or Inactive Ingredients in Drug and Cosmetic Products (40 FR  <!-- PJG 0012 frnewline --> 50527).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable --> 4_S=safety; E=effectiveness  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable --> 5_Determined by the agency to be a ``new drug''. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            